![](/img/cover-not-exists.png)
Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer
Jeffrey R. Infante, Denise A. Yardley, Howard A. Burris III, F. Anthony Greco, Cindy P. Farley, Charles Webb, David R. Spigel, John D. HainsworthVolume:
9
Year:
2009
Language:
english
DOI:
10.3816/cbc.2009.n.004
File:
PDF, 120 KB
english, 2009